Androgen Deprivation Therapy and Future Alzheimer’s Disease Risk

2015198 citationsJournal Articlegreen Open Access

Authors

Kevin T. Nead · Cardiovascular Institute of the South

Greg Gaskin · Cardiovascular Institute of the South

Cariad Chester · Cardiovascular Institute of the South

Samuel Swisher‐McClure · Cardiovascular Institute of the South

Joel T. Dudley · Cardiovascular Institute of the South

Nicholas J. Leeper · Cardiovascular Institute of the South

Nigam H. Shah

Abstract

Our results support an association between the use of ADT in the treatment of prostate cancer and an increased risk of Alzheimer's disease in a general population cohort. This study demonstrates the utility of novel methods to analyze electronic medical record data to generate practice-based evidence.

Topics & Keywords

UN Sustainable Development Goals

Reduced inequalities

Publication Details

Published in: Journal of Clinical Oncology

Volume 34, Issue 6, pp. 566-571

DOI: 10.1200/jco.2015.63.6266

Field-Weighted Citation Impact: 19.37